Thrombolytic Therapy (Tissue Plasminogen Activator - TPA)
Alternate Names : Activase Thrombolytic Agent, Alteplase, Clot-Dissolving Agents, Reperfusion Therapy, Reteplase, Tenecteplase, TPA
 See all Pictures & Images
Risks
Hemorrhage or bleeding is the most common risk associated with the administration of tPA therapy. Bleeding which is mostly minor, such as gum or nose bleeding, can occur in approximately 25% of people, while bleeding into the brain occurs approximately 1% of the time. This is true for both stroke and heart attack patients.
Today's Top News Stories | • | Hopes for AIDS Vaccine Still Alive Despite Setbacks - Dec 01, 2008, 09:00
The lesson from 2 failed trials: The science must be more vigorous, experts say. | • | Guideline Urges HIV Tests for All Patients 13 and Older - Dec 01, 2008, 09:00
Physicians' group, citing World AIDS Day, says colleagues can prevent spread of infection. | • | Scans Show Sound-Processing Deficits in Autistic Kids - Dec 01, 2008, 09:00
Difficulty may underpin language, listening impairments found in disorder, study says. | • | Heavy Traffic Can Be Heartbreaking - Nov 30, 2008, 09:00
Exposure to air pollution is linked to hardening of the arteries. | • | Dry Skin? Don't Let Winter Win - Nov 30, 2008, 15:16
Here are tips for keeping supple in the cold season. |
|
